These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17638924)

  • 1. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells.
    Chow JY; Quach KT; Cabrera BL; Cabral JA; Beck SE; Carethers JM
    Carcinogenesis; 2007 Nov; 28(11):2321-7. PubMed ID: 17638924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
    Giehl K; Seidel B; Gierschik P; Adler G; Menke A
    Oncogene; 2000 Sep; 19(39):4531-41. PubMed ID: 11002426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFbeta modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells.
    Chow JY; Cabral JA; Chang J; Carethers JM
    Cancer Biol Ther; 2008 Oct; 7(10):1694-9. PubMed ID: 18769113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta downregulates PTEN via activation of NF-kappaB in pancreatic cancer cells.
    Chow JY; Ban M; Wu HL; Nguyen F; Huang M; Chung H; Dong H; Carethers JM
    Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G275-82. PubMed ID: 19940030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK.
    Beck SE; Jung BH; Del Rosario E; Gomez J; Carethers JM
    Cell Signal; 2007 Jul; 19(7):1465-72. PubMed ID: 17317101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways.
    Kovacevic Z; Chikhani S; Lui GY; Sivagurunathan S; Richardson DR
    Antioxid Redox Signal; 2013 Mar; 18(8):874-87. PubMed ID: 22462691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1.
    Yan Z; Kim GY; Deng X; Friedman E
    J Biol Chem; 2002 Mar; 277(12):9870-9. PubMed ID: 11784716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta mediates PTEN suppression and cell motility through calcium-dependent PKC-alpha activation in pancreatic cancer cells.
    Chow JY; Dong H; Quach KT; Van Nguyen PN; Chen K; Carethers JM
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G899-905. PubMed ID: 18239055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFbeta-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN.
    Vogelmann R; Nguyen-Tat MD; Giehl K; Adler G; Wedlich D; Menke A
    J Cell Sci; 2005 Oct; 118(Pt 20):4901-12. PubMed ID: 16219695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
    Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
    Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
    Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
    Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP suppresses PTEN expression via RAS/ERK signaling.
    Beck SE; Carethers JM
    Cancer Biol Ther; 2007 Aug; 6(8):1313-7. PubMed ID: 18059158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice.
    Xu X; Ehdaie B; Ohara N; Yoshino T; Deng CX
    Oncogene; 2010 Feb; 29(5):674-86. PubMed ID: 19901970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.
    Yip-Schneider MT; Lin A; Marshall MS
    Biochem Biophys Res Commun; 2001 Feb; 280(4):992-7. PubMed ID: 11162624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs.
    Lin SZ; Xu JB; Ji X; Chen H; Xu HT; Hu P; Chen L; Guo JQ; Chen MY; Lu D; Wang ZH; Tong HF
    Mol Med Rep; 2015 Oct; 12(4):5865-71. PubMed ID: 26238071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
    Park BJ; Park JI; Byun DS; Park JH; Chi SG
    Cancer Res; 2000 Jun; 60(11):3031-8. PubMed ID: 10850453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.